1. New horizons in breast cancer: the promise of immunotherapy

   • L. de la Cruz-Merino
   • N. Palazón-Carrión
   • GEICAM (Spanish Breast Cancer Research Group) and GÉTICA (Spanish Group for Cancer Immuno-Biotherapy)

   Review Article Open access 18 June 2018 Pages: 117 - 125

2. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer

   • N. Sharma
   • M. M. Baruah

   Review Article 27 June 2018 Pages: 126 - 144

   

3. Molecular biomarkers for prognosis of gastrointestinal stromal tumor

   • X. Liu
   • K.-M. Chu

   Review Article 12 July 2018 Pages: 145 - 151

4. Tumor-derived exosomes in cancer metastasis risk diagnosis and metastasis therapy

   • S. Jiang
   • C. Hu
   • M. Lu

   Review Article 26 July 2018 Pages: 152 - 159

   

5. Do locally advanced and metastatic human epithelial cancers evolve in ‘placental/decidual-like microenvironments’?

   • M. Hernández-Bronchud

   Review Article 15 November 2018 Pages: 160 - 166

   

6. CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study

   • X. Zhang
   • J. Zhou
   • G.-L. Shao

   Research Article 12 July 2018 Pages: 167 - 177

   

7. Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation

   • F. Bartel
   • M. van Herk
   • J. Belderbos

   Research Article 06 June 2018 Pages: 178 - 186

   

8. Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era

   • M. Marín
   • C. Gudiol
   • R. Mesia

   Research Article 11 June 2018 Pages: 187 - 196

9. Differential molecular markers of primary lung tumors and metastatic sites indicate different possible treatment selections in patients with metastatic lung adenocarcinoma

   • L.-L. Deng
   • H.-B. Deng
   • Y. Yang

   Research Article 11 June 2018 Pages: 197 - 205

10. The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study

    • T. Karantanos
    • S. Karanika
    • G. Gignac

    Research Article 13 June 2018 Pages: 206 - 212

    

11. The value of radical radiotherapy in the primary tumor of newly diagnosed oligo-metastatic nasopharyngeal carcinoma patients

    • H. Shuang
    • J. Feng
    • C. Xiaozhong

    Research Article 25 June 2018 Pages: 213 - 219

    

12. iTRAQ-based proteomic analysis of DMH-induced colorectal cancer in mice reveals the expressions of β-catenin, decorin, septin-7, and S100A10 expression in 53 cases of human hereditary polyposis colorectal cancer

    • G. Liu
    • F. Fei
    • S. Zhang

    Research Article 28 June 2018 Pages: 220 - 231

    

13. Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification

    • J. Wei
    • T. Yao
    • N. Zhang

    Research Article 02 July 2018 Pages: 232 - 238

    

14. Outcomes of early-stage breast cancer patients treated with sequential anthracyclines–taxanes in relationship to relative dosing intensity: a secondary analysis of a randomized controlled trial

    • O. Abdel-Rahman

    Brief Research Article 28 June 2018 Pages: 239 - 245

    

15. Controversies in the management of stage I seminoma: adjuvant carboplatin revisited

    • J. Aparicio
    • J. Terrasa
    • the Spanish Germ Cell Cancer Group

    Correspondence 10 July 2018 Pages: 246 - 247